Introduction
Molecular-based therapies using antibodies or small molecule inhibitors have recently begun to yield effective anticancer agents. These therapies are ideally based on proteins present in the tumor, but not normal tissue. It therefore seems reasonable to try systematic approaches to identifying new tumor-associated transcripts and proteins, while simultaneously evaluating normal tissue expression. One of many cancers where the discovery of new tumor-associated genes might be useful is the medulloblastoma.
Medulloblastomas are the most common malignant central nervous system (CNS) tumors of childhood. The tumors are classified as invasive primitive neuroectodermal tumors of the cerebellum. Although there is a wide distribution in the age of occurrence, 70% occur in children less than age 16, with a peak age of 7 years. Medulloblastoma patients have a 5-year survival of 50-70%, but the aggressive treatment of children with radiation and chemotherapy frequently results in impaired neural development, growth deficits and endocrine dysfunction.
Gene expression analysis of medulloblastomas using DNA microarrays has recently yielded gene expression patterns associated with decreased survival and treatment failure (Pomeroy et al., 2002) . A similar approach showed that overexpression of the platelet-derived growth factor receptor alpha and members of the RAS/MAPK pathway were associated with medulloblastoma metastasis (MacDonald et al., 2001) . Such studies can potentially help tailor treatment to the molecular profile of the tumor.
The goal of this study was to test a large-scale approach to identifying directly tumor-associated antigens in the medulloblastoma, and to discover potential therapeutic targets for medulloblastoma. Using serial analysis of gene expression (SAGE) (Velculescu et al., 1995) , an average of 70 000 transcripts were counted in 20 medulloblastoma biopsies, and compared to the normal brain adult and pediatric expression. An independent set of medulloblastomas was used to confirm both the transcript and protein levels for candidate targets. Candidate tumor-associated antigens were found by a combination of SAGE, bioinformatics and experimental verification, providing the first step in the discovery process for a molecular target. We are also providing as companion to this study complete on-line expression profiles of the 20 medulloblastomas, as a resource to further stimulate the target discovery for pediatric brain cancers.
Results

Transcript profiles of the medulloblastoma and normal brain
In order to view a deep sample of transcript expression in the medulloblastoma, SAGE analysis was performed on 20 tumors snap frozen immediately after surgery. A total of over 1.4 million tags were obtained with an average of 70 000 tags per library, comprising a total of 236 718 unique transcripts, of which 97 152 were present more than once. The complete tag counts for this deep sampling of a single class of pediatric cancers are posted on the Cancer Genome Anatomy Project's SAGE Genie database for download or on-line analysis (Boon et al., 2002) , as part of this study. SAGE tags from 25 different normal tissue libraries, also totaling B1.4 million tags, were used for comparison to medulloblastoma expression profiles.
Cluster analysis
Hierarchical clustering (Eisen et al., 1998) of the filtered data set (23 054 tags) showed separation of medulloblastoma profiles from the normal neural brain and other normal tissue expression profiles (Figure 1a ). Although the medulloblastomas clustered together, there were no clusters of uniformly highly expressed genes that defined all 20 medulloblastomas. The smaller number of normal tissues did, however, tend to have groups of tissue-specific genes that uniquely defined the normal brain, colon, or muscle tissues (Figure 1b) . Clustering analysis showed no obvious subclasses of medulloblastomas, with the exception of two desmoplastic medulloblastomas (M16 and M17) that clustered together ( Figure 1a ). The analysis did show that many highly expressed genes in common between the medulloblastomas were ribosome-related genes. However, the expression profiles between medulloblastomas were heterogeneous in comparison to normal tissues from the same organ.
Informatic detection of tumor-associated transcripts
Transcripts with a high level of expression in malignant tissue, but not in the normal surrounding tissue, are of particular interest for the identification of novel tumor markers and antigens. Medulloblastomas clustered with each other and away from the normal brain tissues, but we sought the genes that were highly expressed in the medulloblastoma and not expressed in the normal neural tissue. The overall approach we formulated was to compare the expression in the 20 medulloblastomas to six normal neural brain tissue SAGE libraries, including the total brain, thalamus, white matter, cerebellum and pediatric cortex.
Starting with the filtered data set of 23 055 tag sequences detected in the medulloblastoma (see Materials and methods), we selected tags with an expression level of zero counts per 60 000 tags in six normal neural tissue SAGE libraries (thalamus, pediatric cortex, two cerebellum samples, white matter and brain normal pool), reducing the amount of tags to 6164. Next, the When considering all the other normal SAGE libraries from this study, it was observed that eight of these 30 highly expressed tags in the medulloblastoma had no expression in any of the analysed tissues, and could be considered as medulloblastoma specific. Most of these tags matched to ESTs or unknown genes, except for two that were identified as SRY (sex-determining region Y) -box 11 and the musashi Drosophila homolog 1. More important is the observation that four tags showed a significant expression in testis, but not in other normal tissues. Digital Northern analysis using SAGE Genie (Boon et al., 2002) revealed also expression of these tags in other carcinomas. This pattern of expression is consistent with the predicted pattern for cancertestis (CT) antigens. The transcripts tags were identified as unknown mRNA (hypothetical protein NM_152742), thymidylate synthethase, PRAME and topoisomerase II alpha (TOP2A).
PCR confirmation
We sought to verify the SAGE predictions using realtime PCR. From the 14 highly expressed medulloblastoma tags in which a longer mRNA sequence was identified, nine were selected for confirmation with independent samples (Table 1 ). The expression levels of these genes were determined in 44 samples: 20 medulloblastomas independent of the initial SAGE experiment, three samples from the original SAGE experiment (M3, M2 and M8), and 20 samples from various normal tissues, as indicated in Figure 2 . These results clearly show the high expression in medulloblastomas when compared to normal neural and other tissues. From the nine selected genes, eight revealed in at least 20% of the tumors a fourfold overexpression (Table 1) . Besides tumor overexpression, PRAME also had elevated normal expression restricted to the testis, confirming the SAGE data and its previous characterization as a CT antigen (Ikeda et al., 1997; Gure et al., 2000) . Topoisomerase II alpha showed a similar expression pattern as PRAME ( Figure 2 ).
Although no SAGE tags were found in the normal neural tissues for thymosin beta (TMSNB), midkine (MDK), PRAME, prolactin (PRL), topoisomerase II alpha (TOP2A) and N-myc (MYCN), gel electrophoresis of 40 cycles of PCR did show a faint band in some of the normal brain regions (not shown). Lack of detection in the 349 138 SAGE tags collected for the normal neural tissue apparently did not exclude a low average number of normal brain transcripts, in many cases.
We tried to find more genes by relaxing the criteria used in the selection process in such a way that a low expression level (p2 counts per 60 000 tags) in the six neural normal tissues was allowed, and chose 10 tags with the highest expression level in medulloblastomas. Only five of these genes could be confirmed, and are depicted in Table 1 . We concluded from these results that a high level of false positives are introduced when allowing an average expression level of more than 0.8 counts in the neural normal tissue. 
Tissue microarrays
The protein levels of several candidate genes were also analysed on an independent set of tumors immunohistochemically, using a tissue array with 40-60 medulloblastoma samples, depending on the section. Antibodies for CD24, prolactin and TOP2A were first tested on fixed tissue sections from individual tumors, and then used on the array. Immunohistochemical staining was graded as absent, weak, moderate or strong. The M14 anaplastic medulloblastoma was moderately immunoreactive for CD24 (Figure 3a) . Strong (14%) or moderate (42%) staining was also observed for CD24 in 60 medulloblastomas on the tissue array. Strong staining was found for prolactin in M40, a classic medulloblastoma (Figure 3d) . Similar results for prolactin were found on the array for 60 medulloblastoms (24% strong, 32% moderate). These results correspond well with the lower expression of CD24 as compared to the expression of prolactin at the mRNA level found by SAGE and real-time PCR. The adult normal neural tissue was mostly negative for CD24 and prolactin, except for a population of dispersed but strongly staining normal cells (data not shown). These results imply that low SAGE counts (p2 tags per 60 000 total tags) do not exclude significant protein expression of these genes in a small fraction of cells, masked by a large number of cells without gene expression. Paraffin sections of the pediatric cerebellum (new born) showed a similar expression pattern for CD24 and prolactin. In both cases, there is background staining of the outer molecular and granular layer. Interestingly, strong cytoplasmatic staining of the Purkinje cells is seen for CD24 and prolactin (Figure 3c and f ) .
Topoisomerase II alpha antibodies strongly stained two full-sized sections of classic medulloblastoma (Figure 3g) . A tissue microarray analysis containing 40 medulloblastomas showed that 5% were strongly positive and 28% were moderately positive. In contrast to prolactin or CD24, no positive staining cells for topoisomerase II alpha were found in the adult normal cortex (data not shown) or hippocampus (Figure 3k ). In the pediatric cerebellum (new born), the external granular layer cells expressed topoisomerase II alpha (Figure 3i ). This expression was lost in adolescent and adult cerebellum.
Discussion
The transcriptomes of 20 medulloblastomas were sampled to an average of 70 000 transcripts each -one of the most comprehensive SAGE experiments for a particular cancer. Despite the expression of heterogeneity between the 20 tumors, a comparison to the normal neural brain tissue revealed those few genes that are activated in more than 30% of the medulloblastomas. Perhaps most striking is that from over 200 000 unique SAGE transcript tags found in the combined transcriptomes, only 30 tags were highly expressed compared to the normal brain, which met our definition of a tumorassociated antigen within the brain. Using real-time PCR on an independent set of medulloblastomas and normal tissues, we tested nine of the 30 mRNAs, and found that eight transcripts were consistently highly expressed in medulloblastomas. Among the list of selected tumor-associated antigens, N-myc, thymosin beta and CD24 have been previously identified as highly expressed in the medulloblastomas (Garson et al., 1989; Pomeroy et al., 2002) . Further testing of CD24, prolactin and TOP2A by immunohistochemistry on tissue microarrays verified the overexpression of the three proteins. CD24 is a cell-surface molecule expressed in the lung, breast, ovarian and brain cancers (Fogel et al., 1999; Senner et al., 1999; Kristiansen et al., 2002 Kristiansen et al., , 2003 . It is a prognostic marker, and may be involved in invasion (Senner et al., 1999; Kristiansen et al., 2002 Kristiansen et al., , 2003 .
Four medulloblastoma-associated genes identified could be initially classified as candidate CT antigens: PRAME, TOP2A, thymidylate synthetase and a novel gene encoding a hypothetical protein of unknown function. CT antigens are expressed in various tumor types and in normal testes. The best-studied group is the MAGE-1 superfamily (Kirkin et al., 2002) . However, several non-MAGE CT antigens such as the preferentially expressed antigen of melanoma (PRAME) have also been described (Ikeda et al., 1997; Gure et al., 2000; Steinbach et al., 2002) . Additionally, cell-surface antigens, such as the HER-2/neu protein, also show promise as targets for therapeutic monoclonal antibodies (Harries and Smith, 2002) . PRAME is highly expressed in adult leukemia and childhood acute myeloid leukemia (Steinbach et al., 2002) , and has been suggested for use The expression levels were determined by real-time PCR in nine normal neural tissue samples (normal brain, cerebellum, thalamus, gray matter, caudate nucleus and pediatric cortex) and 24 medulloblastoma primary tumors (numbers starting with 'M') and 11 other normal tissues. Each colored bar represents the relative expression level of one gene in various cDNA samples. The selected genes are described in Table 1 Comparison of medulloblastoma and normal transcriptomes K Boon et al in tumor immunotherapy (Ikeda et al., 1997) . Based on our data, it is likely that the nearly one-third of medulloblastomas that express PRAME would benefit from any successful immunotherapy approach targeting PRAME. Topoisomerase II alpha is the molecular target of the anticancer drugs etoposide, doxorubicin and mitoxantrone, and has been identified as a survival marker in astrocytomas (Holden JA, 1999) . Medulloblastomas highly expressing TOP2A may have a different response to these drugs, or new TOP2A inhibitors. Recently, a new topoisomerase II inhibitor S16020 demonstrated a significant antitumor activity in two out of the three medulloblastoma xenografts (Vassal et al., 2003) . Alternatively, immunotherapy targeted against TOP2A might be more successful. Questions remaining are if this and other tumor-associated antigens are immunogenic, and if some normal tissue expression is acceptable, given a sufficient difference in expression between the tumor and normal. Perhaps, not surprisingly, several developmental genes remain activated in these medulloblastomas. For example, the Musashi1 gene, a neural RNA-binding protein, is a reported marker for neural stem cells and malignant gliomas. The expression of Mushashi correlates with the immature nature and the proliferative activity of tumor cells in gliomas (Kanemura et al., 2001) . Although the molecular function of thymosin beta is unknown, this gene is highly similar to thymosin beta 4, which is involved in the development of the rat cerebellum and is expressed at a high level in premigratory granule cells of the external granular layer (Anado´n et al., 2001) . Also, BarHl1 is expressed in migrating cells that give rise to the cerebellar external granular layer in mouse (Bulfone et al., 2000) . The TOP2A expression in the newborn cerebellum found in cells of the external granular layer in the cerebellum also supports the idea that this childhood tumor may indeed rise from granular cell precursors that have failed to regulate (or reactivated) an early developmental phenotype.
In summary, we have identified a set of novel genes expressed in the medulloblastoma but not in the normal brain tissue, that merit further evaluation as therapeutic targets. We were able to verify differential expression in eight of the nine cases we tested, suggesting that most of the genes in our larger set are in fact specifically expressed in these tumors. Most of these candidates have not been previously identified in the medulloblastoma, and our list implicates that several new pathways are being activated in these aggressive neoplasms.
Materials and methods
Tissue and RNAs
Medulloblastomas from seven adults and 32 children were obtained from the NCI Cooperative Human Tissue network (22 samples) and from the Duke Brain Tumor Bank (18 samples). Duke samples were classified based on histology as follows: 14 classic (five subclassified as anaplastic), three large cell and one nodular medulloblastomas. The CHTN samples were classified as 15 medulloblastomas, two desmoplastic medulloblastomas and one nodular medulloblastoma. Pediatric normal cortex (15 months) was a gift of Dr Rachel Myerowitz, and normal pediatric cerebellum was from the Maryland Brain Bank. The normal adult cortex and cerebellum were obtained from the Duke Alzheimer's Brain Bank. The remaining normal tissue total RNA or polyA þ RNA was obtained from various commercial sources, and was also checked by gel electrophoresis prior to SAGE library construction.
SAGE libraries and informatics
SAGE libraries from 20 randomly selected medulloblastoma tumors were constructed using NlaIII as the anchoring enzyme and BsmFI as the tagging enzyme, using a micro-SAGE protocol as previously described (St Croix et al., 2000) . The medulloblastoma SAGE library clones were arrayed at Lawrence Livermore National Laboratories, and inserts were purified and sequenced at the BC Cancer Agency Genome Sciences Centre. SAGE library information and tag counts for the 20 medulloblastoma libraries are posted at CGAP's SAGE Genie website (http://cgap.nci.nih.gov/SAGE) (Boon et al., 2002) in conjunction with this study.
The SAGE 2000 software version 4.12 (available at http:// www.sagenet.org) was used to extract SAGE tags from the original sequence files, remove duplicate ditags, remove linker sequences, remove one base pair variations of linker sequences and tabulate the occurrence of each tag. Tag sequences, tag counts and gene associations were stored in a Microsoft Access relational database for subsequent selection of tags with a particular profile. A total of 1 415 365 tags for the 20 medulloblastoma libraries were obtained with an average of 70 000 tags per library. Normal neural tissue tags included a total of 349 138 tags from the normal brain, cerebellum, thalamus, white matter (Lal et al., 1999; Siu IM, 2001 ) and pediatric cortex. The normal reference tissue SAGE data (1 086 536 tags) included the gastric epithelium, liver, heart, prostate, muscle, lung, leukocytes, kidney, colon, breast, placenta, thyroid, pancreas and testis. Detailed library information and tag counts for each tissue are located at CGAP's SAGE Genie. Tag counts were normalized to 60 000 tags per library.
Hierarchical clustering
The Cluster program developed by Michael Eisen is based on a modified Pearson correlation (Eisen et al., 1998) , and was applied to the normalized SAGE data on 45 libraries described in the previous section. The data were filtered for at least eight observations across the 45 libraries, with an absolute value greater than or equal to 2 and a maximum minus minimum value greater than or equal to 10. These settings produced a data set of 3968 tags. The data set was subsequently adjusted by performing median centering and normalization. This procedure resulted in a median-polished (i.e. all rowand column-wise median values are close to zero) and normal (i.e. all row and column magnitudes are close to 1.0) dataset. Next, the dataset was analysed by applying a correlationcentered complete linkage clustering, which assembles the dataset into a tree. Items joined by short branches are very similar, whereas longer branches represent decreasing similarities. Results were displayed with the TreeView program (Eisen et al., 1998) .
Real-time PCR
Total RNA was extracted from OCT-embedded/fresh frozen tissue from primary tumor samples, using the RNAgents total RNA isolation system (Promega, Madison, WI, USA). Equal amounts of total RNA (2.5 mg), as determined by the RiboGreen RNA Quantification kit (Molecular Probes, Eugene, OR, USA), were used in a 20 ml cDNA synthesis reaction primed with oligo-dT (Superscript II; Invitrogen, Carlsbad, CA, USA). Control reactions were prepared in parallel without reverse transcriptase. Prior to cDNA synthesis, residual genomic DNA was removed from total RNA with a DNase I treatment (DNA-free; Ambion, Austin, TX, USA).
Quantitative PCR was performed with an iCycler IQ realtime detection system (BioRad, Hercules, CA, USA) using SYBR-Green. PCR reactions were performed in triplicate, and the threshold cycle numbers were averaged. Gene expression levels were normalized to three genes: GAPDH, non-POUdomain-containing, octamer-binding (NONO) and ornithine decarboxylase antizyme 1 (OAZ1). NONO and OAZ1 are uniformly expressed, as assessed by SAGE analysis. The relative expression levels were calculated in comparison to the levels in nine normal neural tissues, including the normal brain (3 Â ), cerebellum (2 Â ), thalamus, gray matter, caudate nucleus and pediatric cortex, according to Saha et al. (2001) . A list of the PCR primers used for each gene is available upon request.
Immunohistochemistry
Formalin-fixed, 5-mm and paraffin-embedded sections were stained with hemotoxylin & eosin for histological classification. Immunohistochemistry was performed using the biotin/ streptavidin RTU Vectastain Universal Quick kit (Vector laboratories, Burlingame, CA, USA), with minor modifications according to the manufacturer's instructions. Sections were deparaffinized in HemoD and rehydrated through descending alcohols. Endogenous peroxidase was quenched by incubating the slides in methanol/5% H 2 O 2 at room temperature for 10 min. Nonenzymatic antigen retrieval was performed using the Antigen retrieval solution AR (Biogenex, San Ramon, CA, USA) in combination with microwave treatment. Sections were then blocked in PBS/0.1% BSA or PBS/0.5% Triton X-100 containing 2.5% normal horse serum for at least 10 min at room temperature, and incubated with primary antibody at 371C for 1 h or overnight at 41C. The primary antibodies used were rabbit anti-CD24, goat antiprolactin, both at a 1 : 50 dilution (Santa Cruz Biotechnologies, Santa Cruz, CA, USA), and mouse monoclonal antitopoisomerase II alpha, used at a 1 : 30 dilution (Novocatra Laboratories, New Castle, UK). Sections were developed with a DAB (Sigma, St Louis, MO, USA) substrate, counterstained with hematoxylin and mounted with Cytoseal-60.
Tissue microarrays
The tissue microarray was constructed using previously described methods (Kononen et al., 1998) . At least four representative cores, 0.6 mm in diameter, were taken from each tumor or control tissue, and arrayed in a 380-element recipient block. A neuropathologist selected the tumor areas sampled in each case. The tissue array used in these studies originally contained cores from 72 medulloblastomas, five other central nervous system embryonal tumors and a number of normal tissues. Since some cores did not extend the full length of the block, the actual number of samples for this study varied from 40 to 60 medulloblastomas, depending on the section. Microscopic examination of the array confirmed that the appearance of the tumor tissue cores corresponded to that in the donor blocks.
